The article discusses research on the role of extended-release naltrexone in drug courts. Topics covered include the reported alcohol-impaired driving fatalities in 2008, the lack of availability from drug treatment providers, and the results of treatment with extended-release naltrexone combined with psychosocial support.

Associated Staff